A Clinical Trial for Analysis of Intestinal Microbiome Affecting PK, PD, and Safety of Metformin
Status:
Completed
Trial end date:
2019-02-28
Target enrollment:
Participant gender:
Summary
This clinical trial is intended to evaluate the effects of the changes in intestinal
microbiome by antibiotics (PO vancomycin) on the pharmacokinetic /pharmacodynamic and safety
profiles of metformin in healthy male volunteers.